Leukemia Research
Volume 27, Issue 6 , Pages 467-469 , June 2003

The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomas

Received 29 October 2002 ,Accepted 29 October 2002.

References 

  1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1:703–710
  2. Matas AJ, Simmons RL, Najarian JS. Chronic antigenic stimulation, herpesvirus infection and cancer in transplant recipients. Lancet. 1975;1:1277–1280
  3. Shibata D, Weiss LM, Hernandez AM, et al.  Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus. Blood. 1993;81:2102–2109
  4. Liang R. Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin. Clin. Lymphoma. 2000;1:33–37
  5. Hahn JS, Lee ST, Min YH, et al.  Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma of the upper aerodigestive tract. Yonsei Med. J. 2002;43:175–182
  6. Kim I, Park ER, Park SH, et al.  Characteristics of Epstein-Barr virus isolated from the malignant lymphomas in Korea. J. Med. Virol. 2002;67:59–66
  7. Ohshima K, Liu Q, Koga T, et al.  Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma-natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch. 2002;440:425–435
  8. Lei KI, Chan LY, Chan WY, et al.  Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin. Cancer Res. 2002;8:29–34
  9. Su I, Hsieh H, Lin K, et al.  Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991;77:799–808
  10. Mitarun W, Suwiwat S, Pradutkanchana J, et al.  Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: a clinicopathologic, serologic and molecular analysis. Am. J. Hematol. 2002;70:31–38
  11. Ho JW, Liang RH, Srivastava G. Differential cytokine expression in EBV positive peripheral T-cell lymphomas. Mol. Pathol. 1999;52:269–274
  12. Ho JW, Liang RH, Srivastava G. Preferential type I–I cytokine gene expressions in peripheral T-cell lymphomas. Hematol. Oncol. 1999;17:117–129
  13. Ross ME, Caligiuri MA. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood. 1997;89:910–918
  14. Yamaguchi S, Kitagawa M, Inoue M, et al.  Cell dynamics and expression of tumor necrosis factor (TNF) alpha, interleukin-5 and TNF receptors in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Exp. Mol. Pathol. 2000;68:85–94
  15. Asadullah K, Gellrich S, Haeussler-Quade A, et al.  Cytokine expression in primary cutaneous germinal center cell lymphoma. Exp. Dermatol. 2000;9:71–76
  16. Daliani D, Ulmer RA, Jackow C, et al.  Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein 10. Leuk. Lymphoma. 1998;29:315–328
  17. Mori A, Takao S, Pradutkanchana J, et al. High tumor necrosis factor-α levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma. Leuk Res 2003;27:493–98.
  18. Xu J, Ahmad A, Menezes J. Preferential localization of the Epstein-Barr virus oncoprotein LMP-1 to nuclei of human T-cells: implications for its role in the development of EBV genome-positive T-cell lymphomas. J. Virol. 2002;76:4080–4086
  19. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. New Engl. J. Med. 1998;338:1413–1421

PII: S0145-2126(02)00274-6

doi: 10.1016/S0145-2126(02)00274-6

Leukemia Research
Volume 27, Issue 6 , Pages 467-469 , June 2003

Article Tools